tremelimumab

tremelimumab
Trade Name
Orphan Indication Malignant pleural mesothelioma
USA Market Approval USA
USA Designation Date 2015-03-18 00:00:00
Sponsor MedImmune, LLC;One MedImmune Way;Gaithersburg, Maryland, 20878